Breaking News Instant updates and real-time market news.

ABIO

ARCA Biopharma

$0.39

0.0049 (1.27%)

07:47
02/20/19
02/20
07:47
02/20/19
07:47

ARCA Biopharma announces FDA agreement for Phase 3 PRECISION-AF trial

ARCA Biopharma announced that it has reached agreement with the FDA regarding a special protocol assessment, or SPA, on the design of a Phase 3 clinical trial, PRECISION-AF, to assess the safety and efficacy of Gencaro as a genetically-targeted treatment for atrial fibrillation, or AF, in patients with a specific type of heart failure, or HF. The target population for the planned Phase 3 clinical trial, partially identified by precision therapeutic phenotyping, currently has no FDA approved drug therapies. This SPA provides agreement that the Phase 3 protocol design, clinical endpoints, trial population and statistical analyses adequately address objectives that, if met, would support a regulatory submission seeking approval of Gencaro for the prevention of AF recurrence in a genotype-defined HF population. In accordance with the company's SPA agreement with FDA, PRECISION-AF is designed as a single, adequate and well-controlled Phase 3 clinical trial that may be sufficient to support an new drug application, or NDA, submission for an AF indication if the objectives of the trial are achieved consistent with the requirements of the SPA. The trial is designed as a double-blind, active-controlled, multicenter, international study comparing Gencaro with Toprol-XL for the prevention of AF recurrence or all-cause mortality, or ACM, in HFmrEF patients. HFmrEF is defined as HF with a left ventricular ejection fraction, or LVEF, greater than 40% and less than 50%, which constituted approximately half of the enrolled population in the Phase 2 GENETIC-AF trial. PRECISION-AF is designed to enroll approximately 400 patients who have: HFmrEF, a recent AF event and the genotype which responds most favorably to Gencaro. The primary endpoint of the trial will be time to first event of atrial fibrillation/atrial flutter or ACM during the 26-week follow-up period. Subject to securing additional financing, ARCA anticipates initiating PRECISION-AF in Q4.

TODAY'S FREE FLY STORIES

XOM

Exxon Mobil

$69.11

0.37 (0.54%)

17:58
10/22/19
10/22
17:58
10/22/19
17:58
Periodicals
Exxon lawyer slams NY climate suit as trial opens, Bloomberg says »

Exxon Mobil attorney…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

TER

Teradyne

$59.24

-0.83 (-1.38%)

17:57
10/22/19
10/22
17:57
10/22/19
17:57
Hot Stocks
Teradyne jumps 6% after quarterly results, guidance based on 5G demand »

Shares of semiconductor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 31

    Oct

TER

Teradyne

$59.24

-0.83 (-1.38%)

17:53
10/22/19
10/22
17:53
10/22/19
17:53
Earnings
Teradyne sees Q4 EPS 73c-84c, consensus 61c »

Sees Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 31

    Oct

LEVI

Levi Strauss

$17.59

0.58 (3.41%)

17:52
10/22/19
10/22
17:52
10/22/19
17:52
Hot Stocks
Levi Strauss EVP Love sells 204K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BK

BNY Mellon

$46.15

0.48 (1.05%)

, WFC

Wells Fargo

$50.63

0.18 (0.36%)

17:51
10/22/19
10/22
17:51
10/22/19
17:51
Periodicals
BNY Mellon vice chairman leaves lender, WSJ says »

Bill Daley, former White…

BK

BNY Mellon

$46.15

0.48 (1.05%)

WFC

Wells Fargo

$50.63

0.18 (0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

  • 29

    Oct

  • 12

    Nov

  • 14

    Jan

FMBI

First Midwest

$20.13

0.11 (0.55%)

17:42
10/22/19
10/22
17:42
10/22/19
17:42
Earnings
First Midwest reports Q3 adjusted EPS 52c, consensus 49c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 13

    Nov

GVA

Granite Construction

$36.76

0.44 (1.21%)

17:33
10/22/19
10/22
17:33
10/22/19
17:33
Hot Stocks
Granite Construction awarded $15M airfield contract in North Carolina »

Granite announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

REZI

Resideo

$15.17

0.03 (0.20%)

, STZ

Constellation Brands

$196.67

2.055 (1.06%)

17:32
10/22/19
10/22
17:32
10/22/19
17:32
Hot Stocks
Resideo CFO Joseph Ragan to leave company to pursue other opportunities »

Resideo Technologies…

REZI

Resideo

$15.17

0.03 (0.20%)

STZ

Constellation Brands

$196.67

2.055 (1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNAP

Snap

$14.00

-0.58 (-3.98%)

17:31
10/22/19
10/22
17:31
10/22/19
17:31
Hot Stocks
Snap says average revenue per user was $2.12 in Q3, an increase of 33% y-o-y »

Says maps and gaming are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 21

    Nov

KFS

Kingsway Financial

$2.23

-0.045 (-1.98%)

17:28
10/22/19
10/22
17:28
10/22/19
17:28
Hot Stocks
NYSE extends Kingsway Financial deadline to be current with all SEC filings »

Kingsway Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REZI

Resideo

$15.17

0.03 (0.20%)

17:28
10/22/19
10/22
17:28
10/22/19
17:28
Hot Stocks
Resideo begins comprehensive operational and financial review »

Resideo has begun a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REZI

Resideo

$15.17

0.03 (0.20%)

17:27
10/22/19
10/22
17:27
10/22/19
17:27
Earnings
Resideo cuts FY19 revenue growth view to 2%-4% from 2%-5%, consensus $5.02B »

The company's new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REZI

Resideo

$15.17

0.03 (0.20%)

17:26
10/22/19
10/22
17:26
10/22/19
17:26
Earnings
Resideo reports preliminary Q3 revenue $1.226B, consensus $1.25B »

Reports preliminary Q3…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HNGR

Hanger

$20.50

0.39 (1.94%)

, RTEC

Rudolph Technologies

$27.36

-0.12 (-0.44%)

17:21
10/22/19
10/22
17:21
10/22/19
17:21
Hot Stocks
Hanger to replace Rudolph Technologies in S&P 600 at open on 10/28 »

Nanometrics (NANO) is…

HNGR

Hanger

$20.50

0.39 (1.94%)

RTEC

Rudolph Technologies

$27.36

-0.12 (-0.44%)

NANO

Nanometrics

$34.01

0.03 (0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

  • 07

    Nov

  • 08

    Nov

  • 13

    Nov

PSB

PS Business Parks

$184.20

-1.53 (-0.82%)

17:11
10/22/19
10/22
17:11
10/22/19
17:11
Earnings
PS Business Parks reports Q3 FFO $1.71, two estimates $1.73 »

Reports Q3 rental income…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 12

    Nov

EPSN

Epsilon Energy

$3.20

(0.00%)

17:06
10/22/19
10/22
17:06
10/22/19
17:06
Hot Stocks
Epsilon Energy CEO comments on recent well results »

Michael Raleigh, CEO,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CALX

Calix

$7.15

0.005 (0.07%)

17:06
10/22/19
10/22
17:06
10/22/19
17:06
Earnings
Calix sees Q4 non-GAAP EPS 6c-10c, consensus 11c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

NOW

ServiceNow

$228.26

-12.315 (-5.12%)

17:05
10/22/19
10/22
17:05
10/22/19
17:05
Hot Stocks
Breaking Hot Stocks news story on ServiceNow »

ServiceNow down 6.3% at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

  • 09

    Dec

  • 12

    Dec

CALX

Calix

$7.15

0.005 (0.07%)

17:05
10/22/19
10/22
17:05
10/22/19
17:05
Earnings
Calix reports Q3 non-GAAP EPS 6c, consensus 4c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

GSS

Golden Star Resources

$2.99

0.05 (1.70%)

17:04
10/22/19
10/22
17:04
10/22/19
17:04
Hot Stocks
Golden Star Resources to move corporate office, CFO Andre van Niekerk to leave »

Golden Star Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

TER

Teradyne

$59.24

-0.83 (-1.38%)

17:03
10/22/19
10/22
17:03
10/22/19
17:03
Earnings
Teradyne reports Q3 adjusted EPS 77c, consensus 70c »

Reports Q3 revenue $582M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 31

    Oct

UCBI

United Community Banks

$29.30

0.12 (0.41%)

17:02
10/22/19
10/22
17:02
10/22/19
17:02
Earnings
United Community Banks reports Q3 adjusted EPS 63c, consensus 58c »

On an operating basis,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 13

    Nov

NEM

Newmont Goldcorp

$37.80

-0.17 (-0.45%)

17:01
10/22/19
10/22
17:01
10/22/19
17:01
Hot Stocks
Newmont Goldcorp starting production at Penasquito Mine in Mexico »

Newmont Goldcorp is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

ATR

AptarGroup

$116.78

-1.22 (-1.03%)

17:01
10/22/19
10/22
17:01
10/22/19
17:01
Hot Stocks
AptarGroup says Activ-Blister packaging solution approved by FDA »

AptarGroup announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 12

    Nov

BUSE

First Busey

$25.45

0.05 (0.20%)

17:01
10/22/19
10/22
17:01
10/22/19
17:01
Earnings
First Busey reports Q3 adjusted EPS 55c, consensus 52c »

For the third quarter of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.